RSI welcomes Kannan Krishnan

RSI is pleased to announce that Kannan Krishnan has recently accepted the position of Senior Vice President, Chemical Risk Assessment, effective July 1, 2016.

Kannan will be responsible for conducting chemical risk assessment for our public and private sector clients. Such assessments may include the application of diverse methods and approaches in toxicological risk assessment, such as the application of physiologically-based pharmacokinetic (PBPK) models. He will also be responsible for the supervision of RSI staff working on chemical risk assessments. Kannan is a Diplomate of the American Board of Toxicology, Fellow of the Academy of Toxicological Sciences and fellow of the Canadian Academy of Health Sciences.

Prior to joining RSI, Kannan was at the University of Montreal for over 24 years, where he held appointments as Professor and Director (Occupational and Environmental Health) and Vice-Dean of Research (School of Public Health). He has contributed to over 200 scientific publications on toxicokinetics, PBPK modeling, biomonitoring and risk assessment methodology (including work on chemical mixtures, QSARs, occupational exposure levels, exposure source allocation factors, and human kinetic adjustment factors).

 

 

 

Posted in

More RSI News

Willhite receives prestigious SOT award

December 18, 2020

Calvin C. Willhite, an Associate Expert with Risk Sciences International working on a range of toxicological risk issues, was just announced as the recipient of the prestigious…

Read News Item

RSI gives keynote

October 31, 2020

RSI experts Jennifer Go and Daniel Krewski, were recently invited to present a paper on maternal and child environmental heath during a global, virtual workshop originating in Foshan, Guangdong, China.

Read News Item

RSI hosts Mitacs intern

September 7, 2020

Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at…

Read News Item

Dr. Mattison chairs NAM report

July 24, 2020

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the…

Read News Item